DHODH-IN-11 is a leflunomide derivative and weak dihydroorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.03.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 120 | |
10 mg | In stock | $ 228 | |
20 mg | In stock | $ 319 | |
50 mg | In stock | $ 558 | |
100 mg | In stock | $ 848 |
Description | DHODH-IN-11 is a leflunomide derivative and weak dihydroorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.03. |
Targets&IC50 | DHODH:5.03(pKa) |
In vitro | A compound structurally related to leflunomide was designed, which contained furan ring (compound 14a). Compound 14a undergoes 4 ring cleavage under physiological pH conditions to obtain the corresponding cyanooxime DHODH-IN-11 (compound 14b). DHODH-IN-14 has been analyzed as a DHODH inhibitor; its inefficiency may be due to the unfavorable stereochemistry of the oxime substructure. |
CAS No. | 1263303-95-2 |
Chemical Formula | C15H11N3O2 |
Molecular Weight | 265.272 |
Solubility | DMSO: 10 mM |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom